{{ subpage.title }}

China's Year of Unpredictability | Putin, COVID & Xi’s 3rd Term | GZERO World with Ian Bremmer

China's year of unpredictability

Russia's war in Ukraine has put China in an awkward spot: they condemn the invasion, but not the invader.

Still, it's not really a "limitless" partnership because Xi Jinping has many reasons to be careful about supporting Vladimir Putin, his toxic BFF.

Read Now Show less
China Isn't Budging on Zero-COVID | Quick Take | GZERO Media

China isn't budging on zero-COVID

Ian Bremmer's Quick Take: Hi everybody, Ian Bremmer here. And yes, we are seven weeks into the war, but we also have real problems in containing COVID in China.

In the United States and the rest of the developed world, everyone's saying, "We're done with COVID. We don't want to wear masks anymore. We want to get our lives back." But in China, the zero-COVID policy means that they've got still major lockdowns. In particular, in Shanghai, the largest city in China, which is now entering a second week of lockdown. And record numbers of cases in Shanghai, nothing close to the numbers of cases you were seeing in the United States or in Europe, but in China -- where very few people have gotten COVID, and so there's no natural immunity, vaccines don't work very well and the hospitals would get overwhelmed very quickly if they were just going to let COVID rip -- understandable that they are extremely nervous about these small numbers and as a consequence, they're locking down the entire city.

Read Now Show less
After COVID, Belgian Small Business Began to Bloom | Isabelle Nijs | GZERO Media

After COVID, Belgian small business began to bloom

Isabelle Nijs runs a hair salon in Begijnendijk, Belgium, about an hour’s drive to the northeast of Brussels. Nijs struggled to keep her business going through the pandemic during lockdowns and the lack of customers that brought. Rents and insurance premiums continued going up, but she didn’t get any financial support to meet the rising costs. Now, with people coming out of COVID restrictions, her business has begun to bloom … only to be impacted yet again, this time by the war in Ukraine. Now, she’s also dealing with supply chain issues, with prices going up and quality going down, not to mention long wait times.

Read Now Show less
Mark Suzman’s Big Lesson Learned From COVID | GZERO Media

Mark Suzman’s big lesson learned from COVID

When now-CEO Mark Suzman joined the Bill & Melinda Gates Foundation in 2007, global health efforts were focused on the transition to fighting diseases like HIV, malaria, or TB under initiatives such as The Global Fund or PEPFAR.

Fifteen years later, the main lesson he's learned from COVID is is that "we have and did in the end respond albeit late," Suzman said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill & Melinda Gates Foundation.

Read Now Show less
Should Putin get a Nobel in Medicine for ending talk of COVID? | GZERO Media

Should Putin get a Nobel in Medicine for ending talk of COVID?

José Manuel Barroso, chair of Gavi, The Vaccine Alliance, is having a hard time these days convincing donors to cough up cash for 600 million vaccine doses to serve as a "buffer" for the next COVID wave.

But he's not surprised. Why? Because many people already think the pandemic is over. And for that, he credits Russian President Vladimir Putin, who has diverted global attention away from COVID with his invasion of Ukraine.

Read Now Show less
How the Moderna Vaccine Works, Why It’s Effective, and How It’ll Be Distributed | GZERO World

How the Moderna vaccine works, why it’s effective, and how it’ll be distributed

"What we're trying to do is to educate the immune system to see the protein before it's seen the virus." In a race for a COVID vaccine, Moderna, a 10-year old company with no products previously on the market, developed a vaccine in 10-months, by using revolutionary new mRNA technology. Now the focus shifts to how to distribute and safely administer this vaccine. Moderna co-founder and chairman Noubar Afeyan explains.

His conversation with Ian Bremmer was part of the latest episode of GZERO World, which began airing nationally in the US on public television Friday, December 11th. Check local listings.

Watch the GZERO World episode: A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine

Trump & COVID Sing The Damage Song | PUPPET REGIME | GZERO Media

Trump & COVID sing The Damage Song

Trump & COVID might be on their way out. But there's still time for them to do as much damage as they can.

Watch more PUPPET REGIME.

Ian Bremmer: Latest Vaccine News May Be a Light at the End of the Tunnel | Quick Take | GZERO Media

Quick Take: Latest vaccine news may be a light at the end of the tunnel

Ian Bremmer's Quick Take:

Hey, everybody. Ian Bremmer here, happy Monday, Thanksgiving week. Things starting to look increasingly normal in terms of outlook, in terms of having all of these vaccines. I understand that the next few months in the United States are going to be incredibly challenging, but so much easier when you see that there's light at the end of the tunnel and you know where that's coming. Most recently, the AstraZeneca announcement, which for me, in some ways is a bigger deal globally, even than what we've seen from Moderna and Pfizer, because it doesn't require freezing, it's just refrigeration, which means that countries around the world that don't have the infrastructure to deal with this cold chain requirements of these vaccines will be able to use another set of vaccines with different technology. That's not just AstraZeneca, it will be Johnson and Johnson. It's the Russians. It's the Chinese.

Read Now Show less

Subscribe to GZERO Media's newsletter, Signal

Latest